Pharmacy Times January 3, 2025
Key Takeaways
- CGM demonstrates significant reductions in hemoglobin A1c compared to self-monitoring or usual care, with effect sizes ranging from −0.74% to −0.20%.
- Glycemic variability improvements were noted with CGM, showing increased time in range and decreased time above range, but no significant change in time below range.
- The umbrella review included 31 studies, with 19 systemic reviews showing significant blood glucose improvements with CGM.
- High risk of bias was identified in randomized controlled trials, necessitating further research on patient outcomes and CGM acceptability.
However, the effects on patient-reported outcomes were inconclusive when compared with self-monitoring blood glucose or the usual care.
Continuous glucose monitoring (CGM) demonstrates the potential for better clinical outcomes compared with self-monitoring of blood...
Today's Sponsors
Today's Sponsor
